Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.99m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Form 8 (OPD) - Science Group plc

13 Aug 2021 10:58

RNS Number : 6095I
Science Group PLC
13 August 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Science Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Science Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

12 August 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, TP Group plc

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

1p Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

TOTAL:

Nil

0

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Ordinary Shares of 1 pence each held by directors of Science Group plc:

 

Director

Role

Science Group Ordinary Shares

% of Science Group issued share capital

Martyn Ratcliffe

Chairman & CEO

11,412,080

27.67%

Daniel Edwards

Group Managing Director

109,000

0.26%

Peter Bertram

Independent Non-Executive Director

5,000

0.01%

 

b) Science Group plc 2021 Performance Share Plan ('PSP') granted to directors of Science Group plc:

 

Director

Maximum number of ordinary shares awarded

Date of grant

Exercise price

Exercise period

Jon Brett

10,000

7 October 2020

1 pence

7 October 2023 - 7 October 2030

Daniel Edwards

250,000

14 May 2018

1 pence

14 May 2023 - 14 May 2028

Daniel Edwards

125,000

1 October 2019

1 pence

1 October 2022 - 1 October 2029

Daniel Edwards

40,000

7 October 2020

1 pence

7 October 2023 - 7 October 2030

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

13 August 2021

Contact name:

Sarah Cole

 

Group Legal Counsel & Company Secretary

 

Telephone number:

01223 875 200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEANPDFLEFEEA
Date   Source Headline
16th Mar 20227:00 amRNSAudited Results for year ended 31 December 2021
14th Mar 202211:00 amRNSNotice of Preliminary Results
7th Feb 20227:00 amRNSDirector update
13th Jan 20227:00 amRNS2021 End of Year Trading Update
4th Jan 20223:56 pmRNSTotal Voting Rights
24th Dec 20217:00 amRNSNew Bank Facility
21st Dec 20215:10 pmRNSTransaction in Own Shares
20th Dec 20217:00 amRNSTransaction in Own Shares
16th Dec 202110:30 amRNSCredit Facility to TP Group
26th Nov 20217:00 amRNSFrontier, acquisition and group update
29th Oct 20215:00 pmRNSWithdrawal of GM Requisition - Replacement
29th Oct 20211:20 pmRNSWithdrawal of GM Requisition
26th Oct 20217:00 amRNSRequisition of General Meeting of TP Group plc
15th Oct 20217:00 amRNSIssue of share options & PDMR dealing
11th Oct 20217:00 amRNSTrading and Business Update
30th Sep 20214:45 pmRNSTotal Voting Rights
30th Sep 202111:45 amRNSResult of General Meeting
15th Sep 20217:00 amRNSTR1: Notification of Major Interest in Shares
13th Sep 20214:30 pmRNSTR1: Notification of Major Interest in Shares
13th Sep 20217:00 amRNSNotice of General Meeting
10th Sep 20217:00 amRNSHolding(s) in Company
9th Sep 20217:00 amRNSTP Group General Meeting
8th Sep 20212:00 pmRNSReplacement: Holding(s) in Company
8th Sep 202111:59 amRNSTR1: Notification of Major Interest in Shares
8th Sep 20217:00 amRNSTR1: Notification of Major Interest in Shares
8th Sep 20217:00 amRNSHolding(s) in Company
7th Sep 20211:48 pmRNSConfirmation of fundraising and director dealing
7th Sep 202111:16 amRNSProposed equity placing and director dealing
3rd Sep 202112:00 pmRNSWithdrawal of Possible Offer for TP Group plc
2nd Sep 20215:30 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSForm 8 (DD) - TP Group plc
27th Aug 20215:27 pmRNSForm 8 (DD) - TP Group plc
27th Aug 20217:00 amRNSHolding(s) in Company
27th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
26th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
26th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
26th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
25th Aug 20212:20 pmRNSForm 8 (DD) - TP Group plc
25th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
24th Aug 20215:47 pmRNSHolding(s) in Company
24th Aug 20211:15 pmRNSHolding(s) in Company
24th Aug 20217:01 amRNSStatement re Final Possible Offer for TP Group plc
24th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
23rd Aug 20216:15 pmRNSHolding(s) in Company
23rd Aug 20215:12 pmRNSForm 8.3 - Science Group Plc
23rd Aug 20214:52 pmRNSForm 8.3 - Science Group Plc
23rd Aug 20214:50 pmRNSForm 8.3 - Science Group Plc
23rd Aug 20219:53 amRNSForm 8.5 (EPT/RI)
23rd Aug 20217:00 amRNSHolding(s) in Company
23rd Aug 20217:00 amRNSForm 8 (DD) - TP Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.